Expert commentary from Hope Rugo, MD, on integrating atezolizumab into treatment plans for metastatic TNBC provided by Clinical Care Options (CCO)
Expert commentary from Clinical Care Options (CCO) on managing potential immune-related adverse events associated with atezolizumab treatment for metastatic TNBC
Review key data in the treatment of breast cancer from SABCS 2019 with this set of CME-certified expert commentaries from CCO
Joyce O’Shaughnessy, MD, provides insights on key studies in HR-positive/HER2-negative breast cancer from 2019 SABCS for Clinical Care Options (CCO)
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.